| Marc Andrew Lamacchia, | |
|
15345 Bagley Rd, Cleveland, OH 44130-4825 | |
| (440) 743-8400 | |
| Not Available |
| Full Name | Marc Andrew Lamacchia |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology Assistant |
| Experience | 16 Years |
| Location | 15345 Bagley Rd, Cleveland, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710144126 | NPI | - | NPPES |
| 3017354 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367H00000X | Anesthesiologist Assistant | 67.000144 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Marymount Hospital | Garfield heights, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cleveland Clinic Foundation | 1850203555 | 5690 |
News Archive
The U.S. Food and Drug Administration (FDA) maintains strict labeling requirements for Active Pharmaceutical Ingredients (APIs). If an API does not maintain adequate labeling as per section 502(f)(1) of the Act, the FDA will consider the material to be misbranded. Foreign APIs which are misbranded are subject to detention without physical examination under FDA's Import Alert 66-66 "Red List."
A new clinical trial testing a disease-modifying drug for multiple sclerosis will be the first in the world to recognise the importance of wheelchair users retaining the use of their hands.
Army scientists have demonstrated, for the first time, that antibody-based therapies can successfully protect monkeys from the deadly Ebola and Marburg viruses. In addition, the animals were fully protected even when treatment was administered two days post-infection, an accomplishment unmatched by any experimental therapy for these viruses to date.
A study by an international team of researchers from University College London and the University of Liverpool published in The BMJ predicts that dementia will affect more than 1.2 million people in England and Wales by 2040.
› Verified 6 days ago
| Entity Name | The Cleveland Clinic Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679525919 PECOS PAC ID: 1850203555 Enrollment ID: O20031103000049 |
News Archive
The U.S. Food and Drug Administration (FDA) maintains strict labeling requirements for Active Pharmaceutical Ingredients (APIs). If an API does not maintain adequate labeling as per section 502(f)(1) of the Act, the FDA will consider the material to be misbranded. Foreign APIs which are misbranded are subject to detention without physical examination under FDA's Import Alert 66-66 "Red List."
A new clinical trial testing a disease-modifying drug for multiple sclerosis will be the first in the world to recognise the importance of wheelchair users retaining the use of their hands.
Army scientists have demonstrated, for the first time, that antibody-based therapies can successfully protect monkeys from the deadly Ebola and Marburg viruses. In addition, the animals were fully protected even when treatment was administered two days post-infection, an accomplishment unmatched by any experimental therapy for these viruses to date.
A study by an international team of researchers from University College London and the University of Liverpool published in The BMJ predicts that dementia will affect more than 1.2 million people in England and Wales by 2040.
› Verified 6 days ago
| Entity Name | Ohio Anesthesia Group, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639348113 PECOS PAC ID: 9537222138 Enrollment ID: O20090108000069 |
News Archive
The U.S. Food and Drug Administration (FDA) maintains strict labeling requirements for Active Pharmaceutical Ingredients (APIs). If an API does not maintain adequate labeling as per section 502(f)(1) of the Act, the FDA will consider the material to be misbranded. Foreign APIs which are misbranded are subject to detention without physical examination under FDA's Import Alert 66-66 "Red List."
A new clinical trial testing a disease-modifying drug for multiple sclerosis will be the first in the world to recognise the importance of wheelchair users retaining the use of their hands.
Army scientists have demonstrated, for the first time, that antibody-based therapies can successfully protect monkeys from the deadly Ebola and Marburg viruses. In addition, the animals were fully protected even when treatment was administered two days post-infection, an accomplishment unmatched by any experimental therapy for these viruses to date.
A study by an international team of researchers from University College London and the University of Liverpool published in The BMJ predicts that dementia will affect more than 1.2 million people in England and Wales by 2040.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Marc Andrew Lamacchia, 4450 Belden Village St Nw Ste 307, Canton, OH 44718-2592 Ph: (440) 226-2596 | Marc Andrew Lamacchia, 15345 Bagley Rd, Cleveland, OH 44130-4825 Ph: (440) 743-8400 |
News Archive
The U.S. Food and Drug Administration (FDA) maintains strict labeling requirements for Active Pharmaceutical Ingredients (APIs). If an API does not maintain adequate labeling as per section 502(f)(1) of the Act, the FDA will consider the material to be misbranded. Foreign APIs which are misbranded are subject to detention without physical examination under FDA's Import Alert 66-66 "Red List."
A new clinical trial testing a disease-modifying drug for multiple sclerosis will be the first in the world to recognise the importance of wheelchair users retaining the use of their hands.
Army scientists have demonstrated, for the first time, that antibody-based therapies can successfully protect monkeys from the deadly Ebola and Marburg viruses. In addition, the animals were fully protected even when treatment was administered two days post-infection, an accomplishment unmatched by any experimental therapy for these viruses to date.
A study by an international team of researchers from University College London and the University of Liverpool published in The BMJ predicts that dementia will affect more than 1.2 million people in England and Wales by 2040.
› Verified 6 days ago
Shannon Kelly, AA-C Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 2500 Metrohealth Dr, Cleveland, OH 44109 Phone: 216-778-7800 | |
Olivia Kehoe, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 11100 Euclid Ave, Cleveland, OH 44106 Phone: 216-844-1000 | |
Brian Michael Wheatley, Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 2500 Metrohealth Dr, Cleveland, OH 44109 Phone: 216-778-7800 | |
Nicole M Moses, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 2500 Metrohealth Dr, Cleveland, OH 44109 Phone: 216-778-7800 | |
Michael Marcotte, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 2500 Metrohealth Dr, Cleveland, OH 44109 Phone: 216-778-7800 | |
Thomas Bruno, AA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 11100 Euclid Ave, Cleveland, OH 44106 Phone: 216-844-7330 | |
Gregory G Kychun, AA Anesthesiologist Assistant Medicare: Not Enrolled in Medicare Practice Location: 11100 Euclid Ave, Cleveland, OH 44106 Phone: 216-844-7330 |